Heuser, M., Palmisiano, N., Mantzaris, I., Mims, A., DiNardo, C., Silverman, L. R., . . . Krämer, A. (2020). Safety and efficacy of BAY1436032 in IDH1-mutant AML: Phase I study results. Leukemia.
Chicago Style CitationHeuser, Michael, et al. "Safety and Efficacy of BAY1436032 in IDH1-mutant AML: Phase I Study Results." Leukemia 2020.
MLA CitationHeuser, Michael, et al. "Safety and Efficacy of BAY1436032 in IDH1-mutant AML: Phase I Study Results." Leukemia 2020.
Warning: These citations may not always be 100% accurate.